Levemir is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Insulin Detemir.
Product ID | 50090-4501_826ae8d7-38e5-4686-84ae-4a698a8d86b7 |
NDC | 50090-4501 |
Product Type | Human Prescription Drug |
Proprietary Name | Levemir |
Generic Name | Insulin Detemir |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2013-10-31 |
Marketing Category | BLA / NDA |
Application Number | BLA021536 |
Labeler Name | A-S Medication Solutions |
Substance Name | INSULIN DETEMIR |
Active Ingredient Strength | 100 [iU]/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-09-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021536 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-09-04 |
Ingredient | Strength |
---|---|
INSULIN DETEMIR | 100 [iU]/mL |
SPL SET ID: | 80967086-8161-4ff7-ab17-f03d8319f651 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0169-3687 | Levemir | insulin detemir |
0169-6432 | Levemir | insulin detemir |
0169-6438 | Levemir | insulin detemir |
50090-1276 | Levemir | insulin detemir |
50090-1475 | Levemir | insulin detemir |
50090-4501 | Levemir | insulin detemir |
68258-8977 | Levemir | insulin detemir |
70518-1387 | Levemir | insulin detemir |
70518-1462 | Levemir | insulin detemir |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LEVEMIR 76468735 2808088 Live/Registered |
Novo Nordisk A/S 2002-11-07 |